Kepler Cheuvreux analyst Sebastien Sztabowicz downgrades Nokia (NYSE:NOK) from Buy to Hold.
Why Is Palisade Bio Stock Sinking Today?
Palisade Bio (NASDAQ: PALI) shares are plunging after the company released topline results from the U.S. Phase 2 PROFILE study of LB1148 for post-surgical abdominal adhesions in subjects following elective bowel resection.